174 related articles for article (PubMed ID: 20304825)
1. Human plasmacytoid dendritic cells phagocytose, process, and present exogenous particulate antigen.
Tel J; Lambeck AJ; Cruz LJ; Tacken PJ; de Vries IJ; Figdor CG
J Immunol; 2010 Apr; 184(8):4276-83. PubMed ID: 20304825
[TBL] [Abstract][Full Text] [Related]
2. BDCA-2 signaling inhibits TLR-9-agonist-induced plasmacytoid dendritic cell activation and antigen presentation.
Jähn PS; Zänker KS; Schmitz J; Dzionek A
Cell Immunol; 2010; 265(1):15-22. PubMed ID: 20673884
[TBL] [Abstract][Full Text] [Related]
3. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation.
Guiducci C; Ott G; Chan JH; Damon E; Calacsan C; Matray T; Lee KD; Coffman RL; Barrat FJ
J Exp Med; 2006 Aug; 203(8):1999-2008. PubMed ID: 16864658
[TBL] [Abstract][Full Text] [Related]
4. Targeting uptake receptors on human plasmacytoid dendritic cells triggers antigen cross-presentation and robust type I IFN secretion.
Tel J; Sittig SP; Blom RA; Cruz LJ; Schreibelt G; Figdor CG; de Vries IJ
J Immunol; 2013 Nov; 191(10):5005-12. PubMed ID: 24127556
[TBL] [Abstract][Full Text] [Related]
5. Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells.
Devilder MC; Allain S; Dousset C; Bonneville M; Scotet E
J Immunol; 2009 Sep; 183(6):3625-33. PubMed ID: 19710464
[TBL] [Abstract][Full Text] [Related]
6. Human B cell responses to TLR ligands are differentially modulated by myeloid and plasmacytoid dendritic cells.
Douagi I; Gujer C; Sundling C; Adams WC; Smed-Sörensen A; Seder RA; Karlsson Hedestam GB; Loré K
J Immunol; 2009 Feb; 182(4):1991-2001. PubMed ID: 19201852
[TBL] [Abstract][Full Text] [Related]
7. Antigen targeting to plasmacytoid dendritic cells via Siglec-H inhibits Th cell-dependent autoimmunity.
Loschko J; Heink S; Hackl D; Dudziak D; Reindl W; Korn T; Krug AB
J Immunol; 2011 Dec; 187(12):6346-56. PubMed ID: 22079988
[TBL] [Abstract][Full Text] [Related]
8. CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells.
Marschner A; Rothenfusser S; Hornung V; Prell D; Krug A; Kerkmann M; Wellisch D; Poeck H; Greinacher A; Giese T; Endres S; Hartmann G
Eur J Immunol; 2005 Aug; 35(8):2347-57. PubMed ID: 16025562
[TBL] [Abstract][Full Text] [Related]
9. Functional dichotomy of plasmacytoid dendritic cells: antigen-specific activation of T cells versus production of type I interferon.
Jaehn PS; Zaenker KS; Schmitz J; Dzionek A
Eur J Immunol; 2008 Jul; 38(7):1822-32. PubMed ID: 18581320
[TBL] [Abstract][Full Text] [Related]
10. Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity.
Heit A; Schmitz F; Haas T; Busch DH; Wagner H
Eur J Immunol; 2007 Aug; 37(8):2063-74. PubMed ID: 17628858
[TBL] [Abstract][Full Text] [Related]
11. Human dendritic cells very efficiently present a heterologous antigen expressed on the surface of recombinant gram-positive bacteria to CD4+ T lymphocytes.
Corinti S; Medaglini D; Cavani A; Rescigno M; Pozzi G; Ricciardi-Castagnoli P; Girolomoni G
J Immunol; 1999 Sep; 163(6):3029-36. PubMed ID: 10477566
[TBL] [Abstract][Full Text] [Related]
12. Dominant expression of the inhibitory FcgammaRIIB prevents antigen presentation by murine plasmacytoid dendritic cells.
Flores M; Desai DD; Downie M; Liang B; Reilly MP; McKenzie SE; Clynes R
J Immunol; 2009 Dec; 183(11):7129-39. PubMed ID: 19917701
[TBL] [Abstract][Full Text] [Related]
13. Antigen delivery to plasmacytoid dendritic cells via BST2 induces protective T cell-mediated immunity.
Loschko J; Schlitzer A; Dudziak D; Drexler I; Sandholzer N; Bourquin C; Reindl W; Krug AB
J Immunol; 2011 Jun; 186(12):6718-25. PubMed ID: 21555533
[TBL] [Abstract][Full Text] [Related]
14. The importance of being a pDC in antiviral immunity: the IFN mission versus Ag presentation?
Haeryfar SM
Trends Immunol; 2005 Jun; 26(6):311-7. PubMed ID: 15922947
[TBL] [Abstract][Full Text] [Related]
15. Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides.
Farkas L; Kvale EO; Johansen FE; Jahnsen FL; Lund-Johansen F
J Allergy Clin Immunol; 2004 Aug; 114(2):436-43. PubMed ID: 15316529
[TBL] [Abstract][Full Text] [Related]
16. Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy.
Waeckerle-Men Y; Scandella E; Uetz-Von Allmen E; Ludewig B; Gillessen S; Merkle HP; Gander B; Groettrup M
J Immunol Methods; 2004 Apr; 287(1-2):109-24. PubMed ID: 15099760
[TBL] [Abstract][Full Text] [Related]
17. HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity.
Cederarv M; Söderberg-Nauclér C; Odeberg J
Immunobiology; 2009; 214(5):331-41. PubMed ID: 19152985
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of CpG ODN to CD32 on human and monkey plasmacytoid dendritic cells augments IFNα secretion.
Tel J; Beenhakker N; Koopman G; Hart B; Mudde GC; de Vries IJ
Immunobiology; 2012 Oct; 217(10):1017-24. PubMed ID: 22349518
[TBL] [Abstract][Full Text] [Related]
19. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses.
Bohnenkamp HR; Papazisis KT; Burchell JM; Taylor-Papadimitriou J
Cell Immunol; 2007 Jun; 247(2):72-84. PubMed ID: 17927969
[TBL] [Abstract][Full Text] [Related]
20. Plasmacytoid dendritic cells in the skin: to sense or not to sense nucleic acids.
Conrad C; Meller S; Gilliet M
Semin Immunol; 2009 Jun; 21(3):101-9. PubMed ID: 19250840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
